The study, published in the New England Journal of Medicine, says adults using the drug lorcaserin lost an average of 4kg (8.8lb) over 40 months. It says the drug, which works by suppressing ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

We also have Eisai’s Lorcaserin, which has been tested for a few years in DS. None of these therapies are curative, and they target seizures, not DS itself per se. As I noted before, over 80-90% ...

Among the drugs involved are lorcaserin (developed by Arena Pharmaceuticals) for the treatment of obesity, sodium oxybate (developed by Jazz Pharmaceuticals) for the treatment of fibromyalgia and ...

while Eisai saw the removal from the market of previously approved lorcaserin in 2020 due to increased cancer risk. Such disappointing results of clinical studies enhance some risk to investors ...

Two other examples the company provides are FINTEPLA and lorcaserin, which are from the 5-HT2C agonist class. Both have shown clinical benefit in epilepsy patients, however their non-selectivity ...

Canada residents can call a provincial poison control center. Lorcaserin is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight.

Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss ...